Coronavirus R&D Gateway

‘AstraZeneca has to deliver’, the EU’s health chief says, as row over supplies heats up and officials contradict claims made by pharma company’s CEO

Pharma company shoots down media report, as an extraordinary row over vaccines supply in Europe gets uglier

US biotech Moderna says its vaccine can be repurposed ‘in weeks’ to deal with coronavirus mutations

Open science has been at the heart of the fight-back against the virus. As other crises loom, this underlines the need for governments to avoid protectionist moves and foster collaborative international research

Amid pressure to speed up vaccination programmes some member states are starting to go their own way on securing doses. The EU’s head vaccine official says no country can jump the queue

The pandemic has both spurred on and demonstrated the value of open science, but has also exposed gaps in science policy. Now is a good time for reform, says OECD

President elect vows to ‘follow the science’, setting out a 7-point action plan to beat the pandemic, including $25B to offer every citizen a free COVID-19 vaccine

Faced with the pandemic and an urgent need to re-skill, vocational learning needs to become more attractive, flexible and fit for the digital age and green transition, says the European Commissioner for jobs and social rights

Review of one of the leading vaccine hopes reveals no safety concerns, developers say